A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
Part of paid clinical trials in Azusa, California.
- Sponsor
- Relypsa, Inc.
- Study ID
- NCT01810939
- Phase
- PHASE3
- Status
- Completed
Conditions
- Chronic Kidney Disease (CKD)
- Hyperkalemia (HK)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Patiromer — DRUG
- Placebo — DRUG
Study Details
The purpose of this study was to evaluate the efficacy and safety of patiromer (investigational drug) in the treatment of hyperkalemia (high serum potassium). The study also evaluated the effect of withdrawing patiromer treatment and assessed whether chronic treatment with patiromer prevented the recurrence of hyperkalemia. The safety of patiromer treatment was also evaluated.
Key Dates
- Start date
- Feb 28, 2013
- Status verified
- May 2021
- Primary completion
- Jul 31, 2013
- Completion
- Aug 31, 2013
Study Design
- Enrollment
- 243 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: PatiromerPatiromer was administered twice a day as a powder mixed with water.
- Placebo Comparator: PlaceboPlacebo was administered twice a day as a powder mixed with water.
Primary Outcome Measure
Change in Serum Potassium From Part A Baseline to Part A Week 4 [ Time Frame: Part A Baseline to Part A Week 4 ]
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Investigator Site 3121 | Azusa | California | 91702 | - |
| Investigator Site 3133 | Los Angeles | California | 90025 | - |
| Investigator Site 3103 | Sacramento | California | 95825 | - |
| Investigator Site 3129 | Santa Barbara | California | 93110 | - |
| Investigator Site 3130 | Ventura | California | 93003 | - |
| Investigator Site 3105 | Edgewater | Florida | 32132 | - |
| Investigator Site 3113 | Hollywood | Florida | 33021 | - |
| Investigator Site 3106 | Port Charlotte | Florida | 33952 | - |
| Investigator Site 3120 | Augusta | Georgia | 30909 | - |
| Investigator Site 3102 | Farmington | Missouri | 63640 | - |
| Investigator Site 3104 | Kansas City | Missouri | 64111 | - |
| Investigator Site 3134 | Flushing | New York | 11355 | - |
| Investigator Site 3107 | Bethlehem | Pennsylvania | 18017 | - |
| Investigator Site 3110 | San Antonio | Texas | 78229 | - |
Find similar trials in Azusa, CA
Related Studies
- An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney TransplantRecruiting · Regeneron Pharmaceuticals · Los Angeles, California
- Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.Recruiting · Clindove Research LLC · Brooklyn, New York
- Patient-centered Precision Medicine Lab Result Communication for Older AdultsEnrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- Adia Med of Winter Park LLC Chronic Kidney Disease Research StudyPHASE1 · Recruiting · Adia Med of Winter Park LLC · Winter Park, Florida